• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新定义胰腺癌的R1切除

Redefining the R1 resection in pancreatic cancer.

作者信息

Verbeke C S, Leitch D, Menon K V, McMahon M J, Guillou P J, Anthoney A

机构信息

Department of Histopathology, University of Leeds and Leeds Teaching Hospitals NHS Trust, Leeds, UK.

出版信息

Br J Surg. 2006 Oct;93(10):1232-7. doi: 10.1002/bjs.5397.

DOI:10.1002/bjs.5397
PMID:16804874
Abstract

BACKGROUND

Resection margin (RM) status in pancreatic head adenocarcinoma is assessed histologically, but pathological examination is not standardized. The aim of this study was to assess the influence of standardized pathological examination on the reporting of RM status.

METHODS

A standardized protocol (SP) for pancreaticoduodenectomy specimen examination, involving multicolour margin staining, axial slicing and extensive tissue sampling, was developed. R1 resection was defined as tumour within 1 mm of the RM. A prospective series reported according to this protocol (SP series, n = 54) was compared with a historical matched series in which a non-standardized protocol was used (NSP series, n = 48).

RESULTS

Implementation of the SP resulted in a higher R1 rate overall, and for pancreatic (22 of 26 85 per cent) compared with ampullary (four of 15) and bile duct (six of 13) cancer. Sampling of the circumferential RM was more extensive in the SP series and correlated with RM status. RM involvement was often multifocal (14 of 32), affecting the posterior RM most frequently (21 of 32). Survival correlated with RM status for the entire SP series (P < 0.001), but not for the NSP series. There was a trend towards better median and actuarial 5-year survival after R0 resection in the SP pancreatic cancer subgroup.

CONCLUSION

Standardized examination influences the reporting of RM status.

摘要

背景

胰头腺癌的切缘(RM)状态通过组织学评估,但病理检查并不规范。本研究的目的是评估标准化病理检查对RM状态报告的影响。

方法

制定了一项用于胰十二指肠切除术标本检查的标准化方案(SP),包括多色切缘染色、轴向切片和广泛的组织取样。R1切除定义为肿瘤距RM 1 mm以内。将根据该方案报告的前瞻性系列(SP系列,n = 54)与使用非标准化方案的历史匹配系列(NSP系列,n = 48)进行比较。

结果

实施SP总体上导致R1率更高,与壶腹癌(15例中的4例)和胆管癌(13例中的6例)相比,胰腺癌的R1率更高(26例中的22例,85%)。SP系列中对环周RM的取样更广泛,且与RM状态相关。RM受累通常为多灶性(32例中的14例),最常累及后RM(32例中的21例)。整个SP系列的生存与RM状态相关(P < 0.001),但NSP系列并非如此。在SP胰腺癌亚组中,R0切除后中位生存期和5年精算生存率有改善趋势。

结论

标准化检查影响RM状态的报告。

相似文献

1
Redefining the R1 resection in pancreatic cancer.重新定义胰腺癌的R1切除
Br J Surg. 2006 Oct;93(10):1232-7. doi: 10.1002/bjs.5397.
2
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.胰头可切除腺癌:腹膜后切缘是一个独立的预后因素。
BMC Cancer. 2008 Jan 14;8:5. doi: 10.1186/1471-2407-8-5.
3
R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.R1 切除术在经过标准化病理修正后,对常规使用的胰腺癌的长期预后有显著影响。
Surgery. 2012 Sep;152(3 Suppl 1):S103-11. doi: 10.1016/j.surg.2012.05.015. Epub 2012 Jul 3.
4
Most pancreatic cancer resections are R1 resections.大多数胰腺癌切除术属于R1切除。
Ann Surg Oncol. 2008 Jun;15(6):1651-60. doi: 10.1245/s10434-008-9839-8. Epub 2008 Mar 20.
5
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存:能否治愈?
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.
6
Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins.通过扩大切除范围以实现切缘阴性并不能改善胰十二指肠切除术后的生存率。
Ann Surg. 2009 Jul;250(1):76-80. doi: 10.1097/SLA.0b013e3181ad655e.
7
Resection margin involvement and tumour origin in pancreatic head cancer.胰头癌的切缘累及和肿瘤起源。
Br J Surg. 2012 Aug;99(8):1036-49. doi: 10.1002/bjs.8734. Epub 2012 Apr 20.
8
Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.胰头腺癌门静脉或肠系膜上静脉切除:静脉切除长度的预后价值
Surgery. 2009 Apr;145(4):417-25. doi: 10.1016/j.surg.2008.12.009. Epub 2009 Feb 23.
9
Effect of hospital volume on margin status after pancreaticoduodenectomy for cancer.医院手术量对胰腺癌胰十二指肠切除术后切缘状态的影响。
J Am Coll Surg. 2008 Oct;207(4):510-9. doi: 10.1016/j.jamcollsurg.2008.04.033. Epub 2008 Jun 30.
10
Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.对于交界性胰腺腺癌,在切除术前先进行放化疗,然后再进行化疗。
Am J Surg. 2008 Mar;195(3):318-21. doi: 10.1016/j.amjsurg.2007.12.017.

引用本文的文献

1
Analysis of Short-Term Outcomes in Pancreatic Surgery with Vascular Resection from a Prospective Multicenter Global Study.一项前瞻性多中心全球研究:胰腺手术联合血管切除的短期预后分析
Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-17911-8.
2
Optimizing neoadjuvant chemoradiation in resectable and borderline resectable pancreatic cancer: Evidence-based insights.优化可切除及边界可切除胰腺癌的新辅助放化疗:基于证据的见解
World J Clin Oncol. 2025 Jul 24;16(7):106107. doi: 10.5306/wjco.v16.i7.106107.
3
Great Debate: Chasing Intraoperative Neck Margins During Pancreatoduodenectomy-Beneficial or Not?
大辩论:胰十二指肠切除术中追踪术中颈部切缘——是否有益?
Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17550-z.
4
Changing Clinical Meaning of Resection Margin Status According to the Treatment Paradigm and the Potential Role of Perioperative Radiotherapy for Patients with Pancreatic Ductal Adenocarcinoma: An Updated Multicenter Retrospective Cohort Study.根据治疗模式改变胰腺导管腺癌患者切缘状态的临床意义及围手术期放疗的潜在作用:一项更新的多中心回顾性队列研究
Ann Surg Oncol. 2025 Apr 30. doi: 10.1245/s10434-025-17389-4.
5
Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whipple's (RAW) Study.胰十二指肠切除术治疗胰腺导管腺癌时的静脉切除——Whipple术后复发(RAW)研究的多中心倾向评分匹配分析
Cancers (Basel). 2025 Apr 4;17(7):1223. doi: 10.3390/cancers17071223.
6
Multidisciplinary Therapeutic Approaches to Pancreatic Cancer According to the Resectability Status.根据可切除性状态的胰腺癌多学科治疗方法
J Clin Med. 2025 Feb 11;14(4):1167. doi: 10.3390/jcm14041167.
7
Most oncological pancreas resections must consider the mesopancreas.大多数肿瘤性胰腺切除术必须考虑中胰腺。
BMC Cancer. 2025 Feb 4;25(1):200. doi: 10.1186/s12885-025-13599-x.
8
Surgical and oncological implications of the presence of hepatic artery anatomical variations in patients undergoing pancreaticoduodenectomy: a single center experience.胰十二指肠切除术患者肝动脉解剖变异的手术及肿瘤学意义:单中心经验
Updates Surg. 2025 Apr;77(2):511-521. doi: 10.1007/s13304-025-02079-3. Epub 2025 Jan 29.
9
Intraoperative liquid biopsy as a tool for detecting R1 resection during pancreatoduodenectomy in patients with pancreatic carcinoma: the CETUPANC trial (part II).术中液体活检作为检测胰腺癌患者胰十二指肠切除术中R1切除的工具:CETUPANC试验(第二部分)
Int J Surg. 2024 Dec 1;110(12):7798-7805. doi: 10.1097/JS9.0000000000002153.
10
Bayesan Model to Predict R Status After Neoadjuvant Therapy in Pancreatic Cancer.用于预测胰腺癌新辅助治疗后R状态的贝叶斯模型
Cancers (Basel). 2024 Dec 7;16(23):4106. doi: 10.3390/cancers16234106.